, Tracking Stock Market Picks
Enter Symbol:
Marina Biotech (MRNA) [hlAlert]

down 97.77 %

MDRNA INC (MRNA) rated Buy with price target $4 by Cantor Fitzgerald

Posted on: Wednesday,  Jul 29, 2009  8:25 AM ET by Cantor Fitzgerald

Cantor Fitzgerald rated Buy Marina Biotech (OTCBB: MRNA) on 07/29/2009, when the stock price was $17.80. Since
then, Marina Biotech has lost 97.78% as of 08/27/2015's recent price of $0.40.
If you would have followed this Cantor Fitzgerald's recommendation on MRNA, you would have lost 97.77% of your investment in 2220 days.

MDRNA, Inc. (MDRNA) is a biotechnology company focused on the discovery, development and commercialization of pharmaceuticals based on RNA interference (RNAi). The Company?s infrastructure provides for pre-clinical scale manufacturing of both siRNAs and delivery materials, the comprehensive analysis and optimization of these compounds both individually and as drug candidates, and the filing of Investigational New Drug Applications. The Company develops RNAi-based product candidates for the treatment of cancer, metabolic disorders, inflammation, and viral infections. It focuses on siRNA constructs, such as dicer substrates and three-stranded meroduplexes, and delivery systems for improved siRNA delivery. MDRNA?s various development programs comprise: oncology; metabolic disorders, and inflammation.

Cantor U.S. Equity Research provides timely and insightful opinions on select stocks. We look at key drivers of the stock price, including company and industry fundamentals, capital markets influences and overall economic trends to provide critical and in-depth analysis. Our focus is on small and mid-cap companies in the following sectors: * Marine Transportation * Life Sciences * Clean Technology & Energy Efficiency * Real Estate * Communications Technology * Internet * Enterprise Software
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/29/2009 8:25 AM Buy
17.80 40.00
as of 12/31/2009
1 Week up  36.26 %
1 Month up  49.39 %
3 Months down  -11.42 %
1 YTD up  53.08 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy